Stiolto Respimat is a daily inhaler for COPD, including chronic bronchitis and emphysema. It has two medicines that each help relax the muscles around the airways so breathing is easier. It is a soft-mist inhaler used once a day, not as a rescue inhaler.
Every report comes from a Lived member, sent anonymously.
Have you tried Stiolto Respimat (Tiotropium / Olodaterol) for COPD?
Stiolto Respimat is a prescription inhaler that combines two long-acting airway-opening medicines, tiotropium and olodaterol. It is approved for once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD), the long-term lung disease that includes chronic bronchitis and emphysema. Its job is to keep the airways more open day after day, so breathing is easier and the rescue inhaler is needed less often. It is a maintenance medicine, not a rescue inhaler. It does not relieve a sudden attack of breathlessness, and it should not be started while COPD is rapidly getting worse. It is also not approved for asthma. Olodaterol belongs to a group called long-acting beta-agonists (LABAs), and in asthma a LABA used without an inhaled corticosteroid (a steroid inhaler that calms airway inflammation) raises the risk of serious asthma attacks, including asthma-related death. It is not used in children.
In COPD, the muscles wrapped around the airways tighten and narrow the passages air must travel through. Two separate nerve signals influence that muscle, and each ingredient works on one of them. Tiotropium is an anticholinergic, also called a long-acting muscarinic antagonist (LAMA). It blocks acetylcholine, a chemical messenger that tells airway muscle to contract. Olodaterol is a LABA: it stimulates beta-2 receptors on the same muscle, which tells it to relax. Blocking the tighten signal while boosting the relax signal opens the airways more than either medicine does alone, and both last long enough to cover a full 24 hours from a single daily dose. Neither ingredient treats the underlying lung damage; they make the remaining airways work better.
Stiolto comes as a soft-mist inhaler: a cartridge of liquid medicine fits into a reusable device that turns each dose into a slow-moving mist. The dose is two puffs once a day, taken at the same time each day. Do not take more than two puffs in 24 hours, and do not add extra puffs when breathing feels worse; that is what the rescue inhaler, such as albuterol, is for. Before first use, the cartridge is inserted into the inhaler and the device is primed by spraying it toward the ground until a mist appears, then three more times. If it has not been used for more than 3 days, spray once before the next dose; after more than 21 days, prime it fully again. The standard cartridge holds 60 puffs, which is 30 days of doses, and the inhaler locks when it is empty. Throw it away 3 months after first use even if it has not locked. Keep the mist away from your eyes, and ask the pharmacist or care team to watch your technique if you are unsure.
Most people tolerate Stiolto well. In the main clinical trials, the most common side effects were cold-like symptoms such as a sore throat or runny nose, cough and back pain. Dry mouth, constipation, dizziness and trouble sleeping can also occur. Because olodaterol is related to adrenaline, some people notice a faster heartbeat, palpitations, tremor or nervousness. Persistent palpitations or chest pain should be reported to the prescriber. Two rare reactions need immediate action. Swelling of the lips, tongue or throat, hives or a widespread rash can signal a serious allergic reaction. Wheezing or breathlessness that gets suddenly worse right after a dose can mean the inhaler itself is tightening the airways. In either case, stop using Stiolto and get emergency care; call 911 if breathing is severely difficult or the throat is swelling.
Stiolto should not be combined with another LABA inhaler (such as one containing salmeterol), because doubling up can cause an overdose with dangerous heart effects. It is also best not to use other anticholinergic medicines alongside it, including ipratropium, a related anticholinergic inhaler; people allergic to ipratropium or atropine should tell the prescriber. Beta-blockers, a group of heart and blood pressure medicines, can block olodaterol's effect and tighten the airways, so they need careful choice in COPD. Certain antidepressants and medicines that affect heart rhythm also call for caution, so review every prescription, over-the-counter medicine and supplement with the prescriber or pharmacist. Tiotropium can worsen narrow-angle glaucoma and difficulty urinating. Contact a doctor right away for eye pain, blurred vision or halos around lights with red eyes, or for difficulty or pain passing urine, especially with an enlarged prostate. People with heart disease, seizures, an overactive thyroid or diabetes, and those with reduced kidney function, may need closer monitoring. Dizziness and blurred vision can affect driving. If you are pregnant or breastfeeding, discuss the benefits and risks with your doctor, since there is little human data.
Airways start to open within minutes of the first dose, but the main benefit builds with steady daily use: in clinical trials, people breathed out more air on lung tests and needed their rescue inhaler less than with either ingredient alone, and more of them reported meaningful improvement in day-to-day breathing. These changes are typically modest. Stiolto does not reverse lung damage, and in a large trial it did not clearly reduce flare-ups more than tiotropium on its own. The care team judges the response by symptoms, how often the rescue inhaler is needed, and sometimes lung function tests. Stiolto is usually a long-term medicine; stopping it without a plan can let symptoms return. Needing the rescue inhaler more often than usual, finding it works less well, or breathing that is steadily getting worse are signs COPD may be worsening, and the care team should be contacted promptly rather than taking extra Stiolto.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Stiolto Respimat (Tiotropium / Olodaterol), what you've noticed, or ask the community a question.